Skip to main content
Premium Trial:

Request an Annual Quote

Lawrence Berkeley Lab, Cleveland Clinic Negotiate Licensing Deals

Licensing institution: Lawrence Berkeley National Lab and the US Department of Energy Joint Genome Institute/University of California
Primary inventors: David Humphries and Martin Pollard, staff engineers, LBL and JGI
Licensee: Bio-Rad Laboratories, Hercules, Calif.
Relevant patents: US No. 7,148,778 and US No. 6,954,128, both entitled “High performance hybrid magnetic structure for biotechnology applications.”
Technology: Bio-Rad has licensed a protein and DNA separation technology to be used in life sciences research, food safety testing, and human clinical diagnostics, according to LBL. The technology is a hybrid of permanent magnet and ferromagnetic materials, producing magnetic fields 70 percent higher than the best commercial magnet plates on the market, LBL said.

Licensing institution: Cleveland Clinic
Primary inventor: Anthony Calabro, project staff, biomedical engineering, Cleveland Clinic
Licensee: Lifecore Biomedical
Relevant patent: US No. 6,982,298, “Hydroxyphenyl cross-linked macromolecular network and applications thereof.”
Technology: Lifecore has licensed a Cleveland Clinic-owned hyaluronan-based cross-linking technology that can be used for products in aesthetics, orthopedics, ophthalmology, and other medical fields. Specifically, the technology is a dihydroxyphenyl cross-linked macromolecular network that is useful in artificial tissue and tissue engineering applications, such as artificial or synthetic cartilage.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.